Thursday, December 3, 2009

ADHD Home>
ADHD News>
New ADHD med moves into late-stage studies

Font size
- A
- A
- A
Email This

Bookmark

Save

New ADHD med moves into late-stage studies

(Forbes) UPDATED 2009-07-15

Drugmaker Tergacept's experimental ADHD medication is being moved into late-stage clinical trails, according to the company. The drug--known as AZD3480 or TC-1734--has already completed mid-stage trials for ADHD, as well as for Alzheimer's and Schizophrenia. The medication is part of a new class of drugs called neuronal nicotinic receptor therapeutics, which are aimed at treating central nervous system disorders. Read full story >

See all ADHD News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on ADHDCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.